Skip to main content

Articles

3909 result(s) for 'lung cancer prognosis stage 4' within BMC Cancer

Page 60 of 79

  1. We present the study rationale and design of the JGOG3023 study, an open-label, parallel-arm, randomized, phase II trial that aimed to assess the efficacy and safety of chemotherapy with or without bevacizumab...

    Authors: Tadahiro Shoji, Shinichi Komiyama, Junzo Kigawa, Hiroshi Tanabe, Kazuyoshi Kato, Hiroaki Itamochi, Hiroyuki Fujiwara, Shoji Kamiura, Tetsutaro Hamano and Toru Sugiyama
    Citation: BMC Cancer 2018 18:771
  2. Maspin, a member of the serpin family, is a suppressor of tumor growth, an inhibitor of angiogenesis and an inducer of apoptosis. Maspin induces apoptosis by increasing Bax, a member of the Bcl-2 family of apo...

    Authors: Antonello A Romani, Paolo Soliani, Silvia Desenzani, Angelo F Borghetti and Pellegrino Crafa
    Citation: BMC Cancer 2006 6:255
  3. Segmental genomic copy number alterations, such as loss of 11q or 3p and gain of 17q, are well established markers of poor outcome in neuroblastoma, and have been suggested to comprise tumor suppressor genes o...

    Authors: Sandra Ackermann, Hayriye Kocak, Barbara Hero, Volker Ehemann, Yvonne Kahlert, André Oberthuer, Frederik Roels, Jessica Theißen, Margarete Odenthal, Frank Berthold and Matthias Fischer
    Citation: BMC Cancer 2014 14:840
  4. Traditional therapeutics have encountered a bottleneck caused by diagnosis delay and subjective and unreliable assessment. Biomarkers can overcome this bottleneck and guide us toward personalized precision med...

    Authors: Liang Zhong, Yutong Liu, Kai Wang, Zhijing He, Zhaojian Gong, Zhili Zhao, Yaocheng Yang, Xiaofei Gao, Fangjie Li, Hanjiang Wu, Sheng Zhang and Lin Chen
    Citation: BMC Cancer 2018 18:911
  5. Vascular endothelial growth factor (VEGF) is a primary stimulant of angiogenesis under physiological and pathological conditions. Anti-VEGF therapy is a clinically proven strategy for the treatment of a variet...

    Authors: Kristi D Lynn, D Gomika Udugamasooriya, Christina L Roland, Diego H Castrillon, Thomas J Kodadek and Rolf A Brekken
    Citation: BMC Cancer 2010 10:397
  6. Extranodal natural killer/T-cell lymphoma (ENKL) has heterogeneous clinical manifestations and prognosis. This study aims to evaluate the prognostic impact of absolute monocyte count (AMC) in ENKL, and provide...

    Authors: Jia-Jia Huang, Ya-Jun Li, Yi Xia, Yu Wang, Wen-Xiao Wei, Ying-Jie Zhu, Tong-Yu Lin, Hui-Qiang Huang, Wen-Qi Jiang and Zhi-Ming Li
    Citation: BMC Cancer 2013 13:222
  7. The Notch signaling mutation is associated with enhanced anti-tumor immune response in colorectal cancer (CRC). In this study, we aim to investigate the underlying mechanism and the predictive potential of Not...

    Authors: Fei Wang, Chuan Huang, Jie Long, Zhi-Bin Zhao, Hai-Qing Ma, Xue-Qing Yao, Liang Li and Zhe-Xiong Lian
    Citation: BMC Cancer 2022 22:933
  8. Uterine sarcomas consist a heterogeneous group of mesenchymal gynecological malignancies with unclear therapeutic recommendations and unspecific but poor prognosis, since they usually metastasize and tend to r...

    Authors: Anastasios Kyriazoglou, Michael Liontos, Dimitrios C Ziogas, Flora Zagouri, Kostantinos Koutsoukos, Giorgos Tsironis, Anna Tsiara, Maria Kaparelou, Roubini Zakopoulou, Nikolaos Thomakos, Dimitrios Haidopoulos, Irene Papaspyrou, Alexandros Rodolakis, Aristotelis Bamias and Meletios Athanasios Dimopoulos
    Citation: BMC Cancer 2018 18:1247
  9. To estimate the prognostic value of inflammatory markers in patients with laryngeal squamous cell carcinoma (LSCC).

    Authors: Linyan Chen, Hao Zeng, Jiapeng Yang, Yuqing Lu, Dan Zhang, Jinggan Wang, Chienyun Kuang, Sha Zhu, Manni Wang and Xuelei Ma
    Citation: BMC Cancer 2018 18:816
  10. Accurate regulation of gene expression is crucial for normal development and function of cells. The prognostic significance and potential carcinogenic mechanisms of the related gene JARID2 in OSCC are not yet ...

    Authors: Yuxi Cheng, Zhengzheng Song, Jingyi Cheng and Zhangui Tang
    Citation: BMC Cancer 2024 24:793
  11. Approximately 20 % of hepatocellular carcinoma (HCC) patients diagnosed in the early stages may benefit from potentially curative ablative therapies such as surgical resection, transplantation or radiofrequenc...

    Authors: Mihir Gandhi, Su Pin Choo, Choon Hua Thng, Say Beng Tan, Albert Su Chong Low, Peng Chung Cheow, Anthony Soon Whatt Goh, Kiang Hiong Tay, Richard Hoau Gong Lo, Brian Kim Poh Goh, Jen San Wong, David Chee Eng Ng, Khee Chee Soo, Wei Ming Liew and Pierce K. H. Chow
    Citation: BMC Cancer 2016 16:856
  12. Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) for mucinous cystic neoplasm of the pancreas carries a potential risk of inducing peritoneal tumor cell dissemination. We investigated the diagnost...

    Authors: Rei Suzuki, Hiroki Irie, Tadayuki Takagi, Mitsuru Sugimoto, Naoki Konno, Yuki Sato, Ko Watanabe, Jun Nakamura, Shigeru Marubashi, Takuto Hikichi and Hiromasa Ohira
    Citation: BMC Cancer 2018 18:974
  13. The skeleton is the first and most common distant metastatic site for breast cancer. Such metastases complicate cancer management, inducing considerable morbidities and decreasing patient survival. Osteomimeti...

    Authors: L. Absil, F. Journé, D. Larsimont, J. J. Body, L. Tafforeau and D. Nonclercq
    Citation: BMC Cancer 2020 20:640
  14. Trastuzumab emtansine (T-DM1) is a second-line standard therapy for patients with human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer. Evidence regarding post–T-DM1 treatments is ...

    Authors: Takahiro Nakayama, Tetsuhiro Yoshinami, Hiroyuki Yasojima, Nobuyoshi Kittaka, Masato Takahashi, Shoichiro Ohtani, Seung Jin Kim, Hiroyuki Kurakami, Naoko Yamamoto, Tomomi Yamada, Takehiko Takata and Norikazu Masuda
    Citation: BMC Cancer 2021 21:795
  15. Several physiological (fertilization, placentation, wound healing) and pathophysiological processes (infection with enveloped viruses, cancer) depend on cell fusion. In cancer it was postulated that the fusion...

    Authors: Sera Selina Fahlbusch, Silvia Keil, Jörg T. Epplen, Kurt S. Zänker and Thomas Dittmar
    Citation: BMC Cancer 2020 20:446
  16. The p38 MAPK is constitutively activated in B-NHL cell lines and regulates chemoresistance. Accordingly, we hypothesized that activated p38 MAPK may be associated with the in vivo unresponsiveness to chemotherapy...

    Authors: Gabriel G. Vega, Alejandro Avilés-Salas, J. Ramón Chalapud, Melisa Martinez-Paniagua, Rosana Pelayo, Héctor Mayani, Rogelio Hernandez-Pando, Otoniel Martinez-Maza, Sara Huerta-Yepez, Benjamin Bonavida and Mario I. Vega
    Citation: BMC Cancer 2015 15:722
  17. Though breast cancer remains a major health problem, there is a lack of information on health care provided to patients with this disease and associated costs. In addition, there is a need to update and valida...

    Authors: Susana García-Gutierrez, Miren Orive, Cristina Sarasqueta, Maria Jose Legarreta, Nerea Gonzalez, Maximino Redondo, Amado Rivero, Pedro Serrano-Aguilar, Xavier Castells, Jose Maria Quintana and Maria Sala
    Citation: BMC Cancer 2018 18:54
  18. Advanced esophageal squamous cell cancer (ESCC) is frequently diagnosed in elderly patients. The impact of 2nd line chemotherapy is poorly defined. Recent data demonstrated effectiveness of checkpoint inhibito...

    Authors: Nadja M. Meindl-Beinker, Johannes Betge, Tobias Gutting, Elke Burgermeister, Sebastian Belle, Tianzuo Zhan, Nadine Schulte, Martin Maenz, Matthias P. Ebert and Nicolai Haertel
    Citation: BMC Cancer 2019 19:231
  19. Distant metastasis resulting from vascular dissemination of cancer cells is the primary cause of mortality from breast cancer. We have previously reported that E-selectin expression on the endothelial cell sur...

    Authors: Shin-Ae Kang, Celine A. Blache, Sandra Bajana, Nafis Hasan, Mohamed Kamal, Yoshihiro Morita, Vineet Gupta, Bilegtsaikhan Tsolmon, K. Stephen Suh, David G. Gorenstein, Wajeeha Razaq, Hallgeir Rui and Takemi Tanaka
    Citation: BMC Cancer 2016 16:331

    The Erratum to this article has been published in BMC Cancer 2016 16:370

  20. Esophageal squamous cell carcinoma (ESCC) shows a 5-year survival rate below 10%, demonstrating the urgency in improving its treatment. Alterations in epidermal growth factor receptors are closely related to m...

    Authors: Isabela Martins Gonzaga, Sheila Coelho Soares-Lima, Paulo Thiago Souza de Santos, Tania Cristina Moita Blanco, Bruno Souza Bianchi de Reis, Danielle Carvalho Quintella, Ivanir Martins de Oliveira, Paulo Antonio Silvestre de Faria, Cleber Dario Pinto Kruel, Nelson Adami Andreollo, Tatiana Almeida de Simão and Luis Felipe Ribeiro Pinto
    Citation: BMC Cancer 2012 12:569
  21. Ovarian cancer is associated with poor long-term survival due to late diagnosis and development of chemoresistance. Tumour hypoxia is associated with many features of tumour aggressiveness including increased ...

    Authors: Lynda M. McEvoy, Sharon A. O’Toole, Cathy D. Spillane, Cara M. Martin, Michael F. Gallagher, Britta Stordal, Gordon Blackshields, Orla Sheils and John J. O’Leary
    Citation: BMC Cancer 2015 15:547
  22. Rapidly growing cancer cells secrete growth-promoting polypeptides and have increased proteolytic activity, contributing to tumor progression and metastasis. Their presentation in malignant pleural effusion (M...

    Authors: Li-Han Hsu, Pei-Chi Hsu, Tien-Ling Liao, An-Chen Feng, Nei-Min Chu and Shu-Huei Kao
    Citation: BMC Cancer 2016 16:463
  23. Diffuse large B-cell lymphomas (DLBCLs) display high molecular heterogeneity, but the International Prognostic Index (IPI) considers only clinical indicators and has not been updated to include molecular data....

    Authors: Huilin Peng, Mengmeng Su, Xiang Guo, Liang Shi, Tao Lei, Haifeng Yu, Jieyu Xu, Xiaohua Pan and Xi Chen
    Citation: BMC Cancer 2024 24:621
  24. Hyaluronan is an extracellular matrix glycosaminoglycan involved in invasion, proliferation and metastasis of various types of carcinomas. In many cancers, aberrant hyaluronan expression implicates disease pro...

    Authors: Siiskonen Hanna, Poukka Mari, Tyynelä-Korhonen Kristiina, Sironen Reijo and Pasonen-Seppänen Sanna
    Citation: BMC Cancer 2013 13:181
  25. Colorectal cancer (CRC) is the second leading cause of cancer-related death in men and women. Systemic disease with metastatic spread to distant sites such as the liver reduces the survival rate considerably. ...

    Authors: Derya Bocuk, Alexander Wolff, Petra Krause, Gabriela Salinas, Annalen Bleckmann, Christina Hackl, Tim Beissbarth and Sarah Koenig
    Citation: BMC Cancer 2017 17:342
  26. Baculoviral IAP repeat containing 5 (BIRC5) is overexpressed and plays as a key regulator in the progression of various human carcinomas. The inflammatory tumor microenvironment (ITM) is closely associated wit...

    Authors: Yang Zhao, Songlin Liu, Shuhang Li, Gang Zhang, Aimin Tian and Yinxu Wan
    Citation: BMC Cancer 2022 22:448
  27. Sentinel lymph node (SLN) biopsy has been used to assess patients with papillary thyroid carcinoma (PTC). To achieve its full potential the rate of SLN identification must be as close to 100 percent as possibl...

    Authors: Ou Huang, WeiLi Wu, OuChen Wang, Jie You, Quan Li, DuPing Huang, XiaoQu Hu, JinMiao Qu, Cun Jin, YouQun Xiang, Kai Yang, ShuMei Zhou, XueMin Chen, YiFei Pan, GuiLong Guo and XiaoHua Zhang
    Citation: BMC Cancer 2011 11:386
  28. The incidence of papillary thyroid cancer (PTC) is markedly higher in women than men during the reproductive years. In vitro studies have suggested that estrogen may play an important role in the development and ...

    Authors: Yanhong Huang, Wenwu Dong, Jing Li, Hao Zhang, Zhongyan Shan and Weiping Teng
    Citation: BMC Cancer 2014 14:383
  29. No biomarker exists to guide the optimal choice of chemotherapy for patients with metastatic colorectal cancer. We examined the copy numbers (CN) of topoisomerase I (TOP1) as well as the ratios of TOP1/CEN-20 and...

    Authors: Jesper Andreas Palshof, Estrid Vilma Solyom Høgdall, Tim Svenstrup Poulsen, Dorte Linnemann, Benny Vittrup Jensen, Per Pfeiffer, Line Schmidt Tarpgaard, Nils Brünner, Jan Stenvang, Mette Yilmaz and Dorte Lisbet Nielsen
    Citation: BMC Cancer 2017 17:48
  30. Cyclin B1, the regulatory subunit of cyclin-dependent kinase 1 (Cdk1), is essential for the transition from G2 phase to mitosis. Cyclin B1 is very often found to be overexpressed in primary breast and cervical...

    Authors: Ilija Androic, Andrea Krämer, Ruilan Yan, Franz Rödel, Regine Gätje, Manfred Kaufmann, Klaus Strebhardt and Juping Yuan
    Citation: BMC Cancer 2008 8:391
  31. The obesity and lipid metabolism were previously proposed to be related with the clinical outcomes of metastatic renal cell carcinoma (mRCC). We tried to investigate the relationship between preoperative chole...

    Authors: Hakmin Lee, Yong June Kim, Eu Chang Hwang, Seok Ho Kang, Sung-Hoo Hong, Jinsoo Chung, Tae Gyun Kwon, Cheol Kwak, Hyeon Hoe Kim, Jong Jin Oh, Sang Chul Lee, Sung Kyu Hong, Sang Eun Lee and Seok-Soo Byun
    Citation: BMC Cancer 2017 17:364
  32. Microcalcifications can be the early and only presenting sign of breast cancer. One shared characteristic of breast cancer is the appearance of mammographic mammary microcalcifications that can routinely be us...

    Authors: Andrés M. Castellaro, Alfredo Tonda, Hugo H. Cejas, Héctor Ferreyra, Beatriz L. Caputto, Oscar A. Pucci and German A. Gil
    Citation: BMC Cancer 2015 15:761
  33. This prospective study aimed to compare dose volume histograms (DVH) of the breasts and organs at risk (OARs) of whole breast radiotherapy in the supine and prone positions, and frequency and severity of acute...

    Authors: Kana Takahashi, Madoka Morota, Yoshikazu Kagami, Hiroyuki Okamoto, Shuhei Sekii, Koji Inaba, Naoya Murakami, Hiroshi Igaki, Yoshinori Ito, Takashi Uno and Jun Itami
    Citation: BMC Cancer 2016 16:757
  34. Osteoprotegerin (OPG) is a glycoprotein that has multifaceted role and is associated with several cancer malignancies like that of bladder carcinoma, gastric carcinoma, prostate cancer, multiple myeloma and br...

    Authors: Sudeshna Goswami and Neelam Sharma-Walia
    Citation: BMC Cancer 2015 15:935
  35. Matrix metalloproteinase 7 (MMP7), as the smallest member of the matrix metalloproteinase family, has been verified to be implicated in cancer progression, especially metastasis. However, its expression patter...

    Authors: Shuo Yuan, Li-song Lin, Rui-Huan Gan, Li Huang, Xiao-ting Wu, Yong Zhao, Bo-hua Su, Dali Zheng and You-Guang Lu
    Citation: BMC Cancer 2020 20:33
  36. Even though treatment modalities such as adjuvant systemic radio-chemotherapy and neoadjuvant chemotherapy (NAC) have individually have improved overall survival (OS) and progression-free survival (PFS) rates ...

    Authors: Maneesh Kumarsing Beeharry, Zhen-Tian Ni, Zhong Yin Yang, Ya Nan Zheng, Run Hua Feng, Wen-Tao Liu, Chao Yan, Xue Xin Yao, Chen Li, Min Yan and Zheng-Gang Zhu
    Citation: BMC Cancer 2020 20:224
  37. The aim of this study was to assess the survival outcomes of cisplatin-paclitaxel chemotherapy plus bevacizumab (CPB) versus cisplatin-paclitaxel chemotherapy alone (CPA) in postmenopausal women with previousl...

    Authors: Guanghua Chu, Xiangzhen Liu, Weiguang Yu, Meiji Chen and Lingyun Dong
    Citation: BMC Cancer 2021 21:133
  38. Hepatocellular carcinoma (HCC) is a major health problem worldwide. However, the popular tumor marker, AFP, lacks sensitivity although its specificity is high. Tissue biopsy is an invasive operation and may in...

    Authors: Wene Wei, Mengshu Liu, Shufang Ning, Jing Wei, Jianhong Zhong, Jilin Li, Zhengmin Cai and Litu Zhang
    Citation: BMC Cancer 2020 20:6
  39. Hepatocellular carcinoma (HCC) often arises in the setting of chronic inflammation with multiple inhibitory immune signals. V-domain Ig suppressor of T cell activation (VISTA) is identified as a novel negative...

    Authors: Ming Zhang, Hua-Jin Pang, Wei Zhao, Yu-Fa Li, Li-Xu Yan, Zhong-Yi Dong and Xiao-Feng He
    Citation: BMC Cancer 2018 18:511
  40. A new molecular marker of carcinoma in the urinary bladder is needed as a diagnostic tool or as a therapeutic target. Potential markers include microRNAs (miRNAs), which are short, low molecular weight RNAs 19...

    Authors: Tomomi Fujii, Keiji Shimada, Yoshihiro Tatsumi, Kinta Hatakeyama, Chiho Obayashi, Kiyohide Fujimoto and Noboru Konishi
    Citation: BMC Cancer 2015 15:818
  41. The objective of this work was to assess the overall survival, cause-specific survival and biochemical failure-free survival of a contemporary cohort of patients with localized prostate cancer (PCa) treated wi...

    Authors: Tomás Merino, Ignacio F San Francisco, Pablo A Rojas, Piero Bettoli, Álvaro Zúñiga and Pelayo Besa
    Citation: BMC Cancer 2013 13:530
  42. The response rate of ovarian mucinous carcinomas to paclitaxel/carboplatin is low, prompting interest in targeted molecular therapies. We investigated HER2 expression and amplification, and the potential for t...

    Authors: Jessica N McAlpine, Kimberly C Wiegand, Russell Vang, Brigitte M Ronnett, Anna Adamiak, Martin Köbel, Steve E Kalloger, Kenneth D Swenerton, David G Huntsman, C Blake Gilks and Dianne M Miller
    Citation: BMC Cancer 2009 9:433
  43. Epidemiologic data indicates that Asian diets, which are high in soy protein, reduce a women’s risk of developing breast cancer. However, it has been difficult to dissociate the benefits of soy from other vari...

    Authors: Katrina L Watson, Leanne Stalker, Robert A Jones and Roger A Moorehead
    Citation: BMC Cancer 2015 15:37
  44. Ovarian carcinoma is a rarely curable disease, for which new treatment options are required. As agents that block HMG-CoA reductase and the mevalonate pathway, the statin family of drugs are used in the treatm...

    Authors: Anna Martirosyan, James W Clendening, Carolyn A Goard and Linda Z Penn
    Citation: BMC Cancer 2010 10:103
  45. As ovarian cancer stem cells (CSCs) are responsible for tumor initiation, invasion, metastasis, and chemo-resistance, new stratagems that selectively target ovarian CSCs are critically significant. Our previou...

    Authors: Xiaofen Yao, Zhangli Dong, Qiuwan Zhang, Qian Wang and Dongmei Lai
    Citation: BMC Cancer 2015 15:956
  46. Programmed death-1 ligand-1 (PD-L1) an important cancer biomarker that can suppress the immune system and its high expression is often reported to be related with increased tumor aggressiveness in some cancers...

    Authors: Koji Harada, Tarannum Ferdous and Yoshiya Ueyama
    Citation: BMC Cancer 2018 18:156
  47. Through research on the gut microbiota (GM), increasing evidence has indicated that the GM is associated with esophageal cancer (ESCA). However, the specific cause-and-effect relationship remains unclear. In t...

    Authors: Jia Li, Xuedi Gao, Xiaoming Sun, Hao Li, Jiaheng Wei, Lin Lv and Liangming Zhu
    Citation: BMC Cancer 2024 24:416
  48. This study aimed at the identification of prognostic gene expression markers in early primary colorectal carcinomas without metastasis at the time point of surgery by analyzing genome-wide gene expression prof...

    Authors: Marion Fehlker, Matthew R Huska, Thomas Jöns, Miguel A Andrade-Navarro and Wolfgang Kemmner
    Citation: BMC Cancer 2014 14:64

Featured videos

View featured videos from across the BMC-series journals